Gene Editing in Pluripotent Stem Cells and Their Derived Organoids

Area of Science:

• Regenerative Medicine
• Molecular Biology
• Bioethics

Background:

• Pluripotent stem cells (PSCs) and organoids are vital in regenerative medicine.
• Gene-editing technologies, including CRISPR, have accelerated research and development.
• Both PSCs and gene editing face ethical controversies and safety concerns.

Purpose of the Study:

• To review current gene-editing technology and its applications in PSCs and derived organoids.
• To address ethical concerns and safety risks associated with PSC gene editing.
• To discuss the latest progress and future directions in PSC gene editing.

Main Methods:

• Review of current gene-editing technologies (e.g., CRISPR).
• Application of gene editing in pluripotent stem cells and organoids.
• Analysis of ethical considerations and safety risks.
• Summary of preclinical and clinical trial data.

Main Results:

• Gene editing in PSCs enables the creation of in vitro models for studying mutations.
• It offers new therapeutic possibilities for genetic diseases, cancer, and refractory disorders.
• Preclinical and clinical trials show initial safety and efficacy, warranting further investigation.

Conclusions:

• PSC gene editing holds immense potential for basic and clinical medicine.
• Balancing innovation with ethical and safety regulations is essential for responsible application.
• Continued research is necessary to optimize clinical translation and ensure patient benefit.